Important Updates! It was our Big Day of the 2023 AIM-HI Women’s Venture Competition this…
Congratulations to the inaugural AIM-HI Women’s Venture Competition finalists selected by the Judging Committee, Stacy Blain of Concarlo Holdings and Manijeh Goldberg of Privo Technologies. Not only are they advancing science, but they are also paving the way for more women scientist-entrepreneurs.
The AIM-HI Women’s Venture Competition also hosted a People’s Choice Award for “Best Pitch”, asking the public to select their favorite out of the 8 semi-finalists based on their 1-minute pitch videos. We hope to increase the visibility of these early stage oncology start-ups, spread the word about their innovative technologies and help highlight their marketing skills. The People’s Choice winner went to María José Alonso of Libera Bio.
Stay tuned for the final announcement of the winner of the AIM-HI Women’s Venture Competition, after investment due diligence research is performed on the two finalists.
And THANK YOU to EVERYONE who attended and supported the AIM-HI Women’s Venture Competition, a unique event about giving innovative women leaders an opportunity TODAY, so THEY can make a difference for all of us TOMORROW.
We believe the Awards Ceremony on September 24, 2020 started a new momentum where a special community is being built – a community critically needed to move the needle for oncology start-ups and cancer patients.
We will continue the Women’s Venture Competition every year going forward, providing seed money for the startups to generate dada for proof of concept and proof of value, on the path to clinical trials and, eventually, to new effective therapeutics and diagnostics that could save patients’ lives.
Please consider to partner with us to support the AIM-HI Women’s Venture Competition. DONATE NOW to support the AIM-HI Women’s Competition, and help launch more women scientist-entrepreneurs who are creating life-saving oncology innovations! The impact of your gift is MAGNIFIED. Your generosity truly helps to achieve the impossible.